Advertisements


States fight bonus pay for CEO of OxyContin maker Purdue

The chief executive officer of OxyContin-maker Purdue Pharma LP should not collect a potential $1.3 million bonus when he has been accused of contributing to the opioid epidemic, a group of state attorneys general said in a court filing on Monday......»»

Category: topSource: reutersDec 2nd, 2019

State AGs fight bonus pay for CEO of OxyContin-maker Purdue

The chief executive officer of OxyContin-maker Purdue Pharma LP should not collect a potential $1.3 million bonus when he has been accused of contributing to the opioid epidemic, a group of state attorneys general said in a court filing on Monday......»»

Category: topSource: reutersDec 2nd, 2019

U.S. states fight back against Purdue"s bid to halt opioid lawsuits

U.S. state officials launched a legal counterattack on Friday against Purdue Pharma LP's attempt to shield itself and its controlling Sackler family from thousands of lawsuits claiming the OxyContin maker helped fuel the opioid epidemic......»»

Category: topSource: reutersOct 4th, 2019

Bankruptcy judge considers $1.3M bonus for Purdue Pharma CEO after opioid epidemic

The judge overseeing the bankruptcy case of OxyContin maker Purdue Pharma will consider Wednesday whether the company's CEO should get a bonus equal to half his $2.6 million salary......»»

Category: topSource: foxnewsDec 4th, 2019

OxyContin maker Purdue Pharma to pay states" lawyers, urged to help victims

OxyContin maker Purdue Pharma LP got court approval on Tuesday to reimburse millions of dollars in legal fees for states that back its proposed $10 billion settlement of opioid lawsuits, but with a condition meant to help victims of the addiction crisis......»»

Category: topSource: reutersNov 19th, 2019

OxyContin maker Purdue begins showdown to halt opioid lawsuits

OxyContin maker Purdue Pharma LP will ask a U.S. Bankruptcy Judge on Friday to pause litigation against the company and its owners over the objections of U.S. states that allege the company is trying to protect the controlling Sackler family......»»

Category: topSource: reutersOct 11th, 2019

Sacklers reaped up to $13 billion from OxyContin maker, U.S. states say

OxyContin maker Purdue Pharma LP steered up to $13 billion in profits to the company's controlling Sackler family, according to U.S. states opposing efforts to halt lawsuits alleging the company and its owners helped fuel the U.S. opioid epidemic......»»

Category: topSource: reutersOct 4th, 2019

OxyContin Maker Purdue Pharma Files For Bankruptcy As Dozens Of States Decline Proposed Settlement

OxyCo.....»»

Category: blogSource: zerohedgeSep 16th, 2019

Purdue and Sacklers offer to settle opioid suits for up to $12bn

The states, cities and counties which are pursuing the OxyContin maker because of large bills for cleaning up the opioid crisis are deciding whether to accept the offer by Friday, the people said......»»

Category: topSource: bizjournalsAug 27th, 2019

Five more U.S. states sue OxyContin maker Purdue Pharma over opioid epidemic

Five U.S. states on Thursday filed lawsuits accusing Purdue Pharma LP of illegally marketing and selling opioids, escalating the wave of litigation over a nationwide abuse epidemic......»»

Category: topSource: reutersMay 16th, 2019

6 US states accuse opioid maker Purdue of fueling overdoses

Six U.S. states on Tuesday sued the maker of the opioid OxyContin of using deceptive marketing to boost drug sales that fueled opioid overdose deaths......»»

Category: topSource: foxnewsMay 15th, 2018

Texas sues OxyContin maker for alleged role in nation"s opioid crisis

Texas has joined five other states in filing lawsuits against Purdue Pharma LP, accusing the drug company of igniting the nation’s opioid crisis by using deceptive marketing practices to sell its painkillers. In marketing its drugs, Purdue Phar.....»»

Category: topSource: bizjournalsMay 16th, 2018

North Carolina joins 5 other states in suing the maker of OxyContin

North Carolina has joined five other states in filing lawsuits against Purdue Pharma, accusing the drug company of igniting the nation’s opioid crisis by using deceptive marketing practices to sell its painkillers. In marketing its drugs, Purdue .....»»

Category: topSource: bizjournalsMay 17th, 2018

OxyContin maker Purdue Pharma starts ad campaign for claims

OxyContin maker Purdue Pharma launched an ad campaign Monday to tell people.....»»

Category: topSource: moneycentralFeb 25th, 2020

Exclusive: OxyContin maker Purdue is "Pharma Co X" in U.S. opioid kickback probe - sources

OxyContin maker Purdue Pharma LP is the unnamed company that surfaced in criminal charging documents filed earlier this week in a probe of illegal kickbacks from drugmakers, according to people familiar with the matter......»»

Category: topSource: reutersJan 28th, 2020

Bankruptcy judge thrust into spotlight in Purdue Pharma case

The judge overseeing the bankruptcy of OxyContin maker Purdue Pharma warns that real-life court cases don't unfold like “Perry Mason.” But he’s afraid this one might come to resemble “Dr.... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkDec 24th, 2019

Sacklers withdrew over $10 bnl from Purdue

The Sackler family, owners of Purdue Pharma, transferred more than $10 billion in a decade from the OxyContin maker, according to the New York Times. Fred Katayama reports......»»

Category: videoSource: reutersDec 17th, 2019

Sacklers withdrew over $10 billion in a decade from Purdue Pharma: New York Times

The Sackler family - owners of Purdue Pharma - transferred more than $10 billion in a decade from the OxyContin maker to its trusts and holding companies, the New York Times reported on Monday, citing a new audit commissioned by the drugmaker......»»

Category: topSource: reutersDec 17th, 2019

Sacklers withdrew over $10 billion in a decade from Purdue Pharma: NYT

The Sackler family - owners of Purdue Pharma - transferred more than $10 billion in a decade from the OxyContin maker to its trusts and holding companies, the New York Times reported on Monday, citing a new audit commissioned by the drugmaker......»»

Category: topSource: reutersDec 16th, 2019

Purdue files show it knew cuts wouldn’t kill OxyContin sales

When Purdue Pharma LP cut the last of its sales force in June 2018, some analysts figured the move by the maker of OxyContin painkillers would help address a U.S. opioid-addiction epidemic the company had been accused of creating......»»

Category: dealsSource: nytDec 10th, 2019

Purdue CEO"s bonus pay opposed by 24 states over opioid deaths epidemic

The attorneys general of 24 states said Craig Landau should not collect a bonus that would lift his pay to $3.9 million because of his alleged role in downplaying the risks of Purdue’s drugs......»»

Category: topSource: foxnewsDec 3rd, 2019